Filtros de búsqueda

Lista de obras de

A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases

scientific article published on 13 August 2020

A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis

artículo científico publicado en 2017

A User-Friendly Prediction Tool to Identify Colectomy Risk in Patients With Ulcerative Colitis

scientific article published on 01 August 2019

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease

artículo científico publicado en 2004

A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis

artículo científico publicado en 2006

A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease

artículo científico publicado en 2012

A prospective, randomized, comparative trial evaluating respiratory depression during patient-controlled versus anesthesiologist-administered propofol-remifentanil sedation for elective colonoscopy

artículo científico publicado en 2010

A randomized, controlled, double-blind trial of patient-controlled sedation with propofol/remifentanil versus midazolam/fentanyl for colonoscopy

artículo científico publicado en 2008

ACG Clinical Guideline: Management of Crohn's Disease in Adults

artículo científico publicado en 2018

ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease

artículo científico publicado en 2017

Advances in gastrointestinal pharmacotherapy

artículo científico publicado en 2005

An evidence-based approach to studies of the natural history of gastrointestinal diseases: recurrence of symptomatic Crohn's disease after surgery

scientific article published on 01 May 2003

Antibiotic use and the risk of flare of inflammatory bowel disease

artículo científico publicado en 2005

Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis

artículo científico publicado en 2006

Biosimilars in Inflammatory Bowel Disease

artículo científico publicado en 2020

Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017.

artículo científico publicado en 2018

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis

artículo científico publicado en 2015

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

artículo científico publicado en 2017

Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab

artículo científico publicado en 2009

Colonic dysplasia and cancer in inflammatory bowel disease

artículo científico publicado en 2002

Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update.

artículo científico publicado en 2008

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

scientific article published on 01 February 2004

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

artículo científico publicado en 2010

Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician

scientific article published on 24 August 2020

Correction: ACG Clinical Guideline: Management of Crohn's Disease in Adults

scientific article published on 01 July 2018

Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

artículo científico publicado en 2017

Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

artículo científico publicado en 2017

Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients

artículo científico publicado en 2003

Crohn's disease in the ileal pouch after total colectomy for ulcerative colitis: findings on pouch enemas in six patients

artículo científico publicado en 2005

Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease

artículo científico publicado en 2004

Current and Future Anti-TNF Therapy for Inflammatory Bowel Disease

artículo científico publicado en 2007

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

artículo científico publicado en 2011

Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Restaurantmanhaj's

artículo científico publicado en 2014

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

artículo científico publicado en 2011

Editorial: mesalazine and mucosal microbiome in quiescent ulcerative colitis-what can we learn?

scientific article published on 01 June 2019

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis

artículo científico publicado en 2009

Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis

scientific article published on 01 January 2007

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis

artículo científico publicado en 2002

Emerging Treatment Options in Mild to Moderate Ulcerative Colitis

artículo científico publicado en 2015

Evaluation of polypoid lesions in inflammatory bowel disease

artículo científico publicado en 2002

Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary

scientific article published on 07 September 2018

Exposure to Intravenous Opioids Is Associated With Future Exposure to Opioids in Hospitalized Patients With Inflammatory Bowel Diseases

scientific article published on 27 December 2019

Extraintestinal manifestations of inflammatory bowel disease

scientific article published on 01 March 2002

Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease

scientific article published on 01 May 2006

High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis

scientific article published on 01 January 2008

Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching Hospitals

scientific article published on 01 November 2019

Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease

artículo científico publicado en 2005

Importance of mucosal healing in ulcerative colitis

artículo científico publicado en 2010

Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization.

artículo científico publicado en 2017

Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience.

artículo científico publicado en 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

artículo científico publicado en 2005

Infliximab improves quality of life in patients with Crohn's disease

artículo científico publicado en 2002

Infliximab in fistulizing Crohn's disease

artículo científico publicado en 2006

Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease

scientific article published on 01 April 2005

Infliximab treatment of postoperative ulcers in Crohn's disease: to inject or not to inject--that is the question

artículo científico publicado en 2006

Infliximab use in Crohn's disease

artículo científico publicado en 2005

Infliximab vs Adalimumab for UC: Is There A Difference?

scientific article published on 04 May 2017

Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease ⬇️

artículo científico publicado el 1 de noviembre de 2003

Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission

artículo científico publicado en 2015

Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies

scientific article published on 11 April 2011

Long-term safety and tolerability of once-daily mesalamine granules in the maintenance of remission of ulcerative colitis

artículo científico publicado en 2014

Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts

artículo científico publicado en 2004

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

artículo científico publicado en 2002

Maintenance infliximab therapy in patients with Crohn's disease: how long, how much, how frequent?

scientific article published on 01 June 2003

Management of Crohn's disease in adults.

artículo científico publicado en 2009

Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.

artículo científico publicado en 2008

Mesalamine with MMX technology for the treatment of ulcerative colitis

artículo científico publicado en 2008

Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD: When Trial Design Is as Important as Disease Therapy

scientific article published on 18 March 2020

No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease

artículo científico publicado en 2011

Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.

artículo científico publicado en 2016

Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors

artículo científico

Optimizing therapy in patients with pancolitis

artículo científico publicado en 2005

Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study

artículo científico publicado en 2018

Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study

artículo científico publicado en 2018

Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases

scientific article published on 22 May 2020

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report

scientific article published on 19 July 2018

Prevention and treatment of osteoporosis in inflammatory bowel disease

artículo científico publicado en 2006

Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis

artículo científico publicado en 2006

Recent developments in inflammatory bowel disease

artículo científico publicado en 2002

Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study

artículo científico publicado en 2010

Reliability and initial validation of the ulcerative colitis endoscopic index of severity

artículo científico publicado en 2013

Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.

artículo científico publicado en 2004

Response to Chamberlin and Borody

scientific article published on 01 January 2019

Response to Chapman and Jones

scientific article published on 01 May 2019

Response to Dr Waldum's letter regarding 'Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger-Ellison syndrome and Crohn's disease'

scientific article published on 01 September 2005

Response to Ribaldone

scientific article published on 01 May 2019

Risk for active tuberculosis in inflammatory bowel disease patients

artículo científico publicado en 2007

Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease

artículo científico publicado en 2012

Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis

artículo científico publicado en 2014

Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study

artículo científico

Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.

artículo científico publicado en 2014

Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial

artículo científico publicado en 2007

Safety of anti-TNF therapy in inflammatory bowel disease during pregnancy

artículo científico publicado en 2014

Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease

scientific article published on 01 March 2006

Seasonal variation in flares of inflammatory bowel disease

artículo científico publicado en 2004

Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry

artículo científico publicado en 2012

Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

artículo científico publicado en 2006

Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis

scientific article published on 01 April 2005

Superiority Complex: Do Teaching Hospitals Provide Inferior Care for IBD Patients?

artículo científico publicado en 2020

Survival in elderly patients with ulcerative colitis and colorectal cancer

scientific article published on 01 June 2012

Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab

artículo científico publicado en 2018

Teduglutide in Crohn's disease

artículo científico publicado en 2013

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].

artículo científico publicado en 2015

The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety

artículo científico

The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease

artículo científico publicado en 2006

The effects of infliximab maintenance therapy on health-related quality of life.

artículo científico publicado en 2003

The impact of increased body mass index on the clinical course of Crohn's disease

scientific article published on 01 April 2006

Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data

artículo científico publicado en 2020

Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program

artículo científico publicado en 2020

Treatment of fistulizing Crohn's disease

artículo científico publicado en 2004

Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine

artículo científico publicado en 2004

Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda